John Mascarenhas Selected Research

John Mascarenhas Research Topics

Disease

64	Primary Myelofibrosis (Myelosclerosis) 01/2024 - 06/2012
35	Neoplasms (Cancer) 01/2024 - 11/2010
29	Polycythemia Vera 01/2024 - 05/2009
14	Splenomegaly 12/2023 - 06/2012
13	Essential Thrombocythemia 01/2024 - 06/2014
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023 - 03/2014
8	Thrombosis (Thrombus) 11/2023 - 11/2015
8	Thrombocytopenia (Thrombopenia) 04/2023 - 07/2012
8	Cytopenia 10/2022 - 01/2013
7	Fibrosis (Cirrhosis) 11/2023 - 01/2016
7	Anemia 10/2023 - 01/2015
5	Thrombocytosis (Thrombocythemia) 11/2023 - 07/2012
5	Disease Progression 04/2023 - 03/2016
5	Leukemia 12/2022 - 01/2016
5	Hemorrhage 12/2022 - 01/2018
5	Infections 12/2022 - 03/2014
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2022 - 09/2012
4	Hematologic Neoplasms (Hematological Malignancy) 04/2020 - 06/2012
3	COVID-19 12/2022 - 10/2020
3	Blast Crisis (Blast Phase) 01/2022 - 03/2011
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021 - 04/2020
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2019 - 09/2013
2	Sepsis (Septicemia) 12/2022 - 04/2020
2	Fever (Fevers) 12/2022 - 05/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2021 - 09/2012
2	Bone Marrow Failure Disorders 12/2017 - 03/2014
1	Leukocytosis (Pleocytosis) 11/2023
1	Neurologic Manifestations (Neurological Manifestations) 08/2023
1	Weight Gain 01/2023
1	Lymphoma (Lymphomas) 12/2022
1	Bacterial Infections (Bacterial Infection) 12/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 06/2022
1	Residual Neoplasm 06/2022
1	von Willebrand Diseases (von Willebrand's Disease) 01/2022

Drug/Important Bio-Agent (IBA)

36	ruxolitinibIBA 11/2023 - 06/2012
15	Janus Kinase InhibitorsIBA 12/2023 - 01/2013
12	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 10/2023 - 01/2018
11	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2023 - 03/2016
9	CytokinesIBA 01/2024 - 08/2011
7	InterferonsIBA 01/2024 - 11/2010
7	fedratinibIBA 09/2023 - 01/2020
7	Phosphotransferases (Kinase)IBA 10/2021 - 01/2015
6	Janus KinasesIBA 10/2023 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2011
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
4	Janus Kinase 2IBA 01/2022 - 11/2010
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 03/2016
3	Hemoglobins (Hemoglobin)IBA 11/2023 - 01/2018
3	imetelstatIBA 07/2022 - 10/2021
3	anagrelide (Agrylin)FDA LinkGeneric 01/2022 - 06/2015
3	RG7388IBA 01/2022 - 01/2019
3	AnticoagulantsIBA 10/2021 - 01/2020
3	CollagenIBA 01/2021 - 01/2016
3	Histone Deacetylase InhibitorsIBA 01/2017 - 07/2012
3	PanobinostatIBA 01/2017 - 07/2012
2	Interferon-alpha (Interferon Alfa)IBA 11/2023 - 06/2010
2	Syntex adjuvant formulationIBA 10/2023 - 01/2022
2	micaIBA 12/2022 - 01/2022
2	AntibodiesIBA 12/2022 - 10/2020
2	Immunomodulating AgentsIBA 12/2022 - 11/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2022 - 10/2021
2	peginterferon alfa-2a (Pegasys)FDA Link 01/2022 - 10/2019
2	venetoclaxIBA 04/2021 - 11/2020
2	lestaurtinibIBA 01/2019 - 01/2015
2	Janus Kinase 1IBA 01/2018 - 03/2016
2	Reticulin (Reticular Fiber)IBA 09/2017 - 01/2016
2	Antidepressive Agents (Antidepressants)IBA 01/2017 - 01/2017
2	Thrombopoietin (c-mpl Ligand)IBA 01/2016 - 01/2013
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 02/2014
2	Erythropoietin FDA Link 01/2013 - 04/2012
2	ChromatinIBA 08/2011 - 11/2010
1	Activin Receptors (Activin Receptor)IBA 10/2023
1	activin AIBA 10/2023
1	HepcidinsIBA 10/2023
1	Serum Amyloid P-ComponentIBA 10/2023
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2023
1	Interleukin-15 (Interleukin 15)IBA 12/2022
1	LigandsIBA 12/2022
1	AntigensIBA 12/2022
1	Testosterone CongenersIBA 12/2022
1	FluoroquinolonesIBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2022
1	navtemadlin; 2- ((3R,5R,6S)- 5- (3- chlorophenyl)- 6- (4- chlorophenyl)- 1- ((S)- 1- (isopropylsulfonyl)- 3- methylbutan- 2- yl)- 3- methyl- 2- oxopiperidin- 3- yl)acetic acidIBA 11/2022
1	Immunoglobulin G (IgG)IBA 06/2022
1	blinatumomabIBA 06/2022
1	Immunoglobulins (Immunoglobulin)IBA 06/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2022
1	Drug CombinationsIBA 01/2022
1	dimemorfan (AT 17)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2022

Therapy/Procedure

60	Therapeutics 12/2023 - 06/2010
7	Induction Chemotherapy 12/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 09/2023 - 10/2013
4	Hematopoietic Stem Cell Transplantation 12/2016 - 08/2014
3	Splenectomy 12/2022 - 01/2016
2	Stem Cell Transplantation 12/2023 - 06/2013
2	Transplantation 12/2016 - 09/2012
1	Immunotherapy 12/2022